PALMOPLANTAR PUSTULOSIS
Clinical trials for PALMOPLANTAR PUSTULOSIS explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for painful hand and foot pustules
Disease control CompletedThis study tested a new drug called imsidolimab in 59 adults with palmoplantar pustulosis, a skin condition causing painful pus-filled blisters on the palms and soles. The goal was to see if the drug could reduce the severity of the blisters and scaling. Results suggest the drug …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
AI boosts doctor accuracy for rare skin conditions
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors more accurately diagnose rare and tricky skin conditions like generalized pustular psoriasis (GPP). Fifteen general practitioners and dermatologists reviewed 100 skin images, first giving their own …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated May 17, 2026 02:43 UTC
-
Japanese study reveals Real-World treatment patterns for rare skin condition
Knowledge-focused CompletedThis study looked at how doctors in Japan treat palmoplantar pustulosis (PPP), a skin condition that causes painful blisters on hands and feet. Researchers tracked 276 people already on systemic therapy to see which treatments they used and how long they stayed on them. The goal …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC